Skip to main content
Premium Trial:

Request an Annual Quote

Biosearch Expands License to Roche IVD Patents

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Biosearch Technologies today said that it has expanded its license to certain Roche in vitro diagnostic patents, granting the firm rights to manufacture and sell validated kits covered by the Roche patents to the IVD market.

The kits Biosearch intends to sell will include probes, primers, enzymes, and any other essential reagents necessary to amplify and detect diagnostic targets. As a result, the Novato, Calif.-based firm will expand beyond being a provider of oligonucletoide components for molecular diagnostics to being a provider of diagnostic kits.

Last year, Biosearch had licensed a family of patents from Roche Molecular Systems covering uses of the 5' Nuclease process. It followed that up with a license from the US Centers for Disease Control and Prevention for patents covering the 2009 H1N1 and Influenza A Sub-typing signatures.

"With this expanded Roche license, Biosearch is poised to enter the IVD marketplace as a pivotal manufacturer of diagnostic kits," Marc Beal, director of corporate development at Biosearch Technologies, said in a statement.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.